Evidence map›Paper›PMID 35013485›Full record

ArticleScientific reports2022

Non-invasive scoring of cellular atypia in keratinocyte cancers in 3D LC-OCT images using Deep Learning.

Sébastien Fischman, Javiera Pérez-Anker, Linda Tognetti, Angelo Di Naro, Mariano Suppa, Elisa Cinotti, Théo Viel, Jilliana Monnier, Pietro Rubegni, Véronique Del Marmol and 4 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Digital Dermatology.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Review
  4. Article
  5. An Assessment of Cellular Atypia Utilizing Line-Field Confocal Optical Coherence Tomography (LC-OCT).Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2025
    Article
  6. Quantitative assessment ofBiomedical optics express · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Epidermal renewal during the treatment of atopic dermatitis lesions: A study coupling line-field confocal optical coherence tomography with artificial intelligence quantifications: LC-OCT reveals new biological markers of AD.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  13. Comparison of facial skin ageing in healthy Asian and Caucasian females quantified by in vivo line-field confocal optical coherence tomography 3D imaging.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 4 countries.

Sébastien FischmanDAMAE Medical, Paris, France. sebastien@damae-medical.com.
Javiera Pérez-AnkerMelanoma Unit, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.
Linda TognettiDermatology Unit - Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Angelo Di NaroDermatology Unit - Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Mariano SuppaDepartment of Dermatology, Université Libre de Bruxelles, Hôpital Erasme, Brussels, Belgium.
Elisa CinottiDermatology Unit - Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Théo VielDAMAE Medical, Paris, France.
Jilliana MonnierGroupe d'Imagerie Cutanée Non Invasive (GICNI) of the Société Française de Dermatologie (SFD), Paris, France.
Pietro RubegniDermatology Unit - Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Véronique Del MarmolDepartment of Dermatology, Université Libre de Bruxelles, Hôpital Erasme, Brussels, Belgium.
Josep MalvehyMelanoma Unit, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.
Susana PuigMelanoma Unit, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.
Arnaud DuboisUniversité Paris-Saclay, Institut d'Optique Graduate School, Laboratoire Charles Fabry, Palaiseau, France.
Jean-Luc PerrotDepartment of Dermatology, University Hospital of Saint-Etienne, Saint-Etienne, France.
University of Siena · ITSociété Française de Cardiologie · FRCentre Hospitalier Universitaire de Saint-Étienne · FRCentro de Investigación Biomédica en Red · ESErasmus Hospital · BEInstituto de Salud Carlos III · ESUniversitat de Barcelona · ESUniversité Libre de Bruxelles · BEUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosis based on histopathology for skin cancer detection is today's gold standard and relies on the presence or absence of biomarkers and cellular atypia. However it suffers drawbacks: it requires a strong expertise and is time-consuming. Moreover the notion of atypia or dysplasia of the visible cells used for diagnosis is very subjective, with poor inter-rater agreement reported in the literature. Lastly, histology requires a biopsy which is an invasive procedure and only captures a small sample of the lesion, which is insufficient in the context of large fields of cancerization. Here we demonstrate that the notion of cellular atypia can be objectively defined and quantified with a non-invasive in-vivo approach in three dimensions (3D). A Deep Learning (DL) algorithm is trained to segment keratinocyte (KC) nuclei from Line-field Confocal Optical Coherence Tomography (LC-OCT) 3D images. Based on these segmentations, a series of quantitative, reproducible and biologically relevant metrics is derived to describe KC nuclei individually. We show that, using those metrics, simple and more complex definitions of atypia can be derived to discriminate between healthy and pathological skins, achieving Area Under the ROC Curve (AUC) scores superior than 0.965, largely outperforming medical experts on the same task with an AUC of 0.766. All together, our approach and findings open the door to a precise quantitative monitoring of skin lesions and treatments, offering a promising non-invasive tool for clinical studies to demonstrate the effects of a treatment and for clinicians to assess the severity of a lesion and follow the evolution of pre-cancerous lesions over time.

Indexed as

Deep LearningAdultAgedAged, 80 and overAlgorithmsFemaleHistological TechniquesHumansImaging, Three-DimensionalKeratinocytesMaleMiddle AgedPathologySkinSkin NeoplasmsTomography, Optical Coherence

Identifiers

PMID35013485
PMCPMC8748986
OpenAlexW4206180729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.